The Board of Directors of KNC Laboratories Co., Ltd. has authorized a buyback plan on May 13, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,400 JPY | +0.14% | +0.72% | -3.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.65% | 68.21M | |
+4.70% | 103B | |
+2.40% | 65.6B | |
+42.86% | 39.06B | |
+16.96% | 37.58B | |
+6.96% | 33.26B | |
+7.89% | 19.22B | |
+12.12% | 16.83B | |
+12.08% | 15.03B | |
+17.69% | 14.96B |
- Stock Market
- Equities
- 6568 Stock
- News KNC Laboratories Co., Ltd.
- KNC Laboratories Co., Ltd. authorizes a Buyback Plan.